home *** CD-ROM | disk | FTP | other *** search
/ Corel Medical Series: Cancer / Corel Medical Series: Cancer.iso / mac / Program / shared.cxt / 00245_Field_HOTLINKDATABASE.txt < prev    next >
Text File  |  1997-02-06  |  14KB  |  281 lines

  1. SRC.c01.A.1,see Kidney cancer,c17.A.6
  2. SRC.c01.A.6,SEE "THYROID",C42.A.1
  3. SRC.c01.C.1,see Kidney cancer,c17.C.6
  4. SRC.c01.C.6,SEE "THYROID",C42.C.1
  5. SRC.c02.A.17,see Laser Therapy,p09.a.1
  6. SRC.c03.A.1,see diagram in Gall Bladder Cancer,c13.a.8
  7. SRC.C03.C.1,see diagram in Gall Bladder Cancer,c13.c.8
  8. SRC.c06.A.13,see BIOPSY DIAGRAM,p02.a.24
  9. SRC.c06.A.23,RADIATION THERAPY,p06.A.16
  10. SRC.c06.A.23,TREATMENT SIDE EFFECTS,p17.A.1
  11. SRC.c06.A.28,see BONE MARROW TRANSPLANTATION,P12.a.10
  12. SRC.c06.A.28,see BIOLOGICAL THERAPY,P08.A.17
  13. SRC.c06.A.36,see "STAGE II",c06.a.34
  14. SRC.c06.A.48,"STAGE IIIA",C06.A.39
  15. SRC.c06.A.48,"STAGE IV",C06.A.41
  16. SRC.c06.A.48,see INVESTIGATIONAL ANTICANCER DRUGS,P35.A.1
  17. SRC.c06.C.13,see BIOPSY DIAGRAM,p02.C.24
  18. SRC.c06.C.24,RADIATION THERAPY,p06.C.16
  19. SRC.c06.C.24,TREATMENT SIDE EFFECTS,p17.C.1
  20. SRC.c06.C.28,see BONE MARROW TRANSPLANTATION,P12.C.10
  21. SRC.c06.C.29,see BIOLOGICAL THERAPY,P08.C.17
  22. SRC.c06.C.38,SEE "STAGE II",C06.c.36
  23. SRC.c06.C.51,"STAGE IIIA",C06.C.42
  24. SRC.c06.C.51,"STAGE IV",C06.A.44
  25. SRC.c06.C.51,see INVESTIGATIONAL ANTICANCER DRUGS,P35.C.1
  26. SRC.c07.A.3,see also "SPECIAL PATHOLOGIC METHODS",C07.A.7
  27. SRC.c07.C.4,see also "SPECIAL PATHOLOGIC METHODS",C07.C.8
  28. SRC.c08.A.13,see "RECURRENT CANCER",C08.A.15
  29. SRC.c08.C.14,see "RECURRENT CANCER",C08.C.16
  30. SRC.c08.C.2,SEE "COMMON SIGNS AND SYMPTOMS",C08.C.5
  31. SRC.c08.A.2,see"Common Signs and Symptoms",C08.A.5
  32. SRC.c10a.A.15,see BONE MARROW TRANSPLANTATION,P12.A.24
  33. SRC.c10a.A.3,SEE "RISK FACTORS",C10A.A.5
  34. SRC.c10a.C.15,see BONE MARROW TRANSPLANTATION,P12.C.23
  35. SRC.c10a.C.3,SEE "RISK FACTORS",C10A.C.5
  36. SRC.c11b.A.1,see Living with an Ostomy,P21.A.1
  37. SRC.c11b.A.13,See also STAGE II.,C11B.A.7
  38. SRC.c11b.A.15,see WHAT HAPPENS IN SURGERY,P05.A.1
  39. SRC.c11b.A.19,see "Metastatic Cancer",C27.A.12
  40. SRC.c11b.A.21,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.A.16
  41. SRC.c11b.A.21,See Investigational Anticancer Drugs,P35.A.13
  42. SRC.c11b.A.3,see LASER THERAPY,P09.A.7
  43. SRC.c11b.C.1,see UNDERSTANDING AN OSTOMY,P21.C.1
  44. SRC.c11b.C.13,See also STAGE II.,C11B.C.7
  45. SRC.c11b.C.15,see WHAT HAPPENS IN SURGERY,P05.C.1
  46. SRC.c11b.C.16,see "METASTATIC CANCER",C27.C.11
  47. SRC.c11b.C.19,see "METASTATIC CANCER",C27.C.12
  48. SRC.c11b.C.21,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.C.17
  49. SRC.c11b.c.21,See Investigational Anticancer Drugs,P35.C.9
  50. SRC.c11b.C.3,see LASER THERAPY,P09.C.7
  51. SRC.c11c.A.11,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.A.16
  52. SRC.c11c.A.13,SEE "STAGE IV",C11C.A.10
  53. SRC.c11c.A.2,see OSTOMY,P21.a.1
  54. SRC.c11c.A.4,see LASER THERAPY,P09.A.7
  55. SRC.c11c.A.5,See Stage 1 Colon Cancer Diagram,C11B.A.6
  56. SRC.c11c.A.6,See STAGE II COLON DIAGRAM,C11B.A.7
  57. SRC.c11c.A.8,See STAGE III COLON DIAGRAM,C11B.a.10
  58. SRC.c11c.C.12,See Summary of Consensus Conference on Colon and Rectal Cancer,C11C.C.17
  59. SRC.c11c.C.14,SEE "STAGE IV",C11C.C.11
  60. SRC.c11c.C.2,see OSTOMY,P21.C.1
  61. SRC.c11c.C.4,see LASER THERAPY,P09.C.7
  62. SRC.c31.A.12,See Maintaining Good Nutritrion,P18.A.1
  63. SRC.c31.A.15,see Stage 1,c31.A.13
  64. SRC.c31.A.17,see STAGES II,c31.A.14
  65. SRC.c31.A.17,III,c31.A.16
  66. SRC.c31.A.2,See Diagram,c13.a.8
  67. SRC.c31.C.12,See Maintaining Good Nutritrion,P18.C.1
  68. SRC.c31.C.15,see "Palliation" section,c31.C.11
  69. SRC.c31.C.17,see Stages II,c31.A.14
  70. SRC.c31.C.17,III,c31.A.16
  71. SRC.c31.C.2,See Diagram,c13.a.8
  72. SRC.c31.C.2,see "ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.c.1
  73. SRC.c32.A.1,see Figure,c42.A.6
  74. SRC.c32.C.1,see "Thyroid",c42.C.6
  75. SRC.c34.A.1,see Areas in the brain,c05.A.5
  76. SRC.c34.C.1,see Areas in the brain,c05.C.6
  77. SRC.c36.A.14,see "Childhood Cancer: Soft Tissue And Bone Sarcomas",c10d.A.1
  78. SRC.c36.C.14,see "Childhood Cancer: Soft Tissue And Bone Sarcomas",c10d.C.1
  79. SRC.c36.A.1,CHILDHOOD CANCERS: SOFT TISSUE AND BONE SARCOMAS,c10d.A.1
  80. SRC.c36.A.1,KAPOSI'S SARCOMA,c16.A.1
  81. SRC.c36.A.1,MESOTHELIOMA,c26.A.1
  82. SRC.c36.A.1,UTERUS: UTERINE SARCOMAS,c45.A.1
  83. SRC.c36.C.1,CHILDHOOD CANCERS: SOFT TISSUE AND BONE SARCOMAS,c10d.C.1
  84. SRC.c36.C.1,KAPOSI'S SARCOMA,c16.C.1
  85. SRC.c36.C.1,MESOTHELIOMA,c26.C.1
  86. SRC.c36.C.1,UTERUS: UTERINE SARCOMAS,c45.C.1
  87. SRC.c37.A.1,see also "Melanoma",c25.A.1
  88. SRC.c37.C.1,see also "Melanoma",c25.C.1
  89. SRC.c38.A.13,See "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.A.1
  90. SRC.c38.A.13,see "LYMPHOMAS: NON-HODGKIN'S",c24.A.1
  91. SRC.c38.A.15,see "MAINTAINING GOOD NUTRITION",p18.A.1
  92. SRC.c38.A.2,see "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.A.1
  93. SRC.c38.C.13,See "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.C.1
  94. SRC.c38.C.13,see "LYMPHOMAS: NON-HODGKIN'S",c24.C.1
  95. SRC.c38.C.15,see "MAINTAINING GOOD NUTRITION",p18.C.1
  96. SRC.c38.C.2,see "CARCINOIDS OF THE GASTROINTESTINAL TRACT",c08.C.1
  97. SRC.c39.A.22,see "LASER THERAPY",p09.A.1
  98. SRC.c39.C.21,see "LASER THERAPY",p09.C.1
  99. SRC.c42.A.2,"Adrenal Gland",c01.A.1
  100. SRC.c42.A.2,"PARATHYROID",c32.A.1
  101. SRC.c42.A.2,"ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.A.1
  102. SRC.c42.A.23,see "LYMPHOMAS: NON-HODGKIN'S",c24.A.1
  103. SRC.c42.C.2,"Adrenal Gland",c01.C.1
  104. SRC.c42.C.2,"PARATHYROID",c32.C.1
  105. SRC.c42.C.2,"ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.C.1
  106. SRC.c42.C.24,see "LYMPHOMAS: NON-HODGKIN'S",c24.C.1
  107. SRC.c44.A.2,See "UTERUS: UTERINE SARCOMAS".,c45.A.1
  108. SRC.c44.A.2,see Cancers of female pelvic organs,c09.A.4
  109. SRC.c44.A.2,See OVARIAN GERM CELL TUMORS.",c30.A.1
  110. SRC.c44.A.7,see Endometrial Cancer Precursors,c44.A.9
  111. SRC.c44.C.2,See "UTERUS: UTERINE SARCOMAS.",c45.C.1
  112. SRC.c44.C.2,see Cancers of female pelvic organs,c09.C.4
  113. SRC.c44.C.2,See "OVARY.",c29.C.1
  114. SRC.c45.A.1,see "UTERUS: ENDOMETRIAL CARCINOMA",c44.A.1
  115. SRC.c45.A.1,see "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
  116. SRC.c45.A.2,see "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
  117. SRC.c45.C.1,see "UTERUS: ENDOMETRIAL CARCINOMA",c44.C.1
  118. SRC.c45.C.1,see "CERVIX",c09.C.1
  119. SRC.c45.C.2,see "CANCERS OF FEMALE PELVIC ORGANS",c09.C.4
  120. SRC.C45.A.5, See "Uterus: Endometrial Carcinoma",c44.A.1
  121. SRC.C45.A.6, See "Uterus: Endometrial Carcinoma",c44.A.1
  122. SRC.C45.A.7, See "Uterus: Endometrial Carcinoma",c44.A.1
  123. SRC.C45.A.8, See "Uterus: Endometrial Carcinoma",c44.A.1
  124. SRC.C45.A.9, See "Uterus: Endometrial Carcinoma",c44.A.1
  125. SRC.C45.A.15,See "Endometrial Carcinoma",c44.A.1
  126. SRC.C45.A.18,See "Endometrial Carcinoma",c44.A.1
  127. SRC.C45.C.5,See "Uterus: Endometrial Carcinoma",c44.C.1
  128. SRC.C45.C.6,See "Uterus: Endometrial Carcinoma",c44.C.1
  129. SRC.C45.C.7,See "Uterus: Endometrial Carcinoma",c44.C.1
  130. SRC.C45.C.8,See "Uterus: Endometrial Carcinoma",c44.C.1
  131. SRC.C45.C.9,See "Uterus: Endometrial Carcinoma",c44.C.1
  132. SRC.C45.C.15,See "Endometrial Carcinoma",c44.C.1
  133. SRC.C45.C.18,See "Endometrial Carcinoma",c44.C.1
  134. SRC.c46.A.14,see "MELANOMA",c25.A.1
  135. SRC.c46.A.2,See "CANCERS OF FEMALE PELVIC ORGANS",c09.A.4
  136. SRC.c46.C.13,see "MELANOMA",c25.C.1
  137. SRC.c46.C.2,See "CANCERS OF FEMALE PELVIC ORGANS",C09.C.4
  138. SRC.c47.A.2,See "CANCERS OF FEMALE PELVIC ORGANS",C09.A.4
  139. SRC.c47.C.2,See "CANCERS OF FEMALE PELVIC ORGANS",c09.C.4
  140. SRC.P01.A.9,SEE INVESTIGATIONAL ANTICANCER DRUGS,P34.A.1
  141. SRC.P01.C.9,SEE INVESTIGATIONAL ANTICANCER DRUGS,P34.C.1
  142. SRC.p01.A.18,see TABLE: Staging For Breast Carcinoma,P01.A.19
  143. SRC.p01.C.18,see TABLE: Staging For Breast Carcinoma,P01.C.19
  144. SRC.p02.A.17,see "LASER THERAPY",p09.A.1
  145. SRC.p02.C.18,see "LASER THERAPY",p09.C.1
  146. SRC.p02.A.22,see Figure: TYPES OF BIOPSY FOR CANCER DIAGNOSIS,p02.A.24
  147. SRC.p02.A.6,see Bronchoscope,p02.A.22
  148. SRC.p02.C.17,see "LASER THERAPY",p09.C.1
  149. SRC.p02.C.22,see Figure: TYPES OF BIOPSY FOR CANCER DIAGNOSIS,p02.C.24
  150. SRC.p02.C.6,see Bronchoscope,p02.C.22
  151. SRC.p03.A.17,see "SURVIVORSHIP",p31.A.1
  152. SRC.p03.C.18,see "SURVIVORSHIP",p31.C.1
  153. SRC.p03.A.5,see "THE ONCOLOGY NURSE",p15.A.1
  154. SRC.p03.C.5,see "THE ONCOLOGY NURSE",p15.C.1
  155. SRC.p04.A.11,see "ACCESS TO CANCER INFORMATION",p37.A.1
  156. SRC.p04.C.11,see "ACCESS TO CANCER INFORMATION",p37.C.1
  157. SRC.c11c.C.5,See Stage 1 Colon Cancer Diagram,c11b.c.6
  158. SRC.c11c.C.6,see Stage II colon diagram,c11b.c.7
  159. SRC.c11c.C.9,see Stage III colon diagram,c11b.c.10
  160. SRC.c12.A.14,see "STOMACH",c39.a.1
  161. SRC.c12.A.15,see Laser Therapy,p09.a.1
  162. SRC.c12.A.20,see Laser Therapy,p09.a.1
  163. SRC.c12.C.14,see "STOMACH",c39.c.1
  164. SRC.c12.C.15,see Laser Therapy,p09.c.1
  165. SRC.c12.C.20,see Laser Therapy,p09.c.1
  166. SRC.c14a.A.3,see also "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
  167. SRC.c14a.C.2,see also "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
  168. SRC.c15.A.1,see Diagram in Gall Bladder Cancer,c13.A.8
  169. SRC.c15.C.1,see Diagram in Gall Bladder Cancer,c13.C.8
  170. SRC.c16.A.22,see The Look Good...Feel Better Cosmetic Program,p22.A.1
  171. SRC.c16.C.22,see The Look Good...Feel Better Cosmetic Program,p22.C.1
  172. SRC.c17.A.2,See "CHILDHOOD CANCERS",c10a.a.1
  173. SRC.c17.C.2,See "CHILDHOOD CANCERS",c10a.c.1
  174. SRC.c18.A.10,see Bone Marrow Transplantation,p12.a.1
  175. SRC.c18.C.10,see Bone Marrow Transplantation,p12.c.1
  176. SRC.c19.A.1,see "BILE DUCT",c03.a.1
  177. SRC.c19.A.2,see "METASTATIC CANCER",c27.a.1
  178. SRC.c19.A.2,see Diagram in Gall Bladder Cancer,c13.a.8
  179. SRC.c19.C.2,see "BILE DUCT",c03.c.1
  180. SRC.c19.C.2,see "METASTATIC CANCER",c27.c.1
  181. SRC.c20.C.23,See Treatment for Stage IV disease,c20.C.18
  182. SRC.c20.A.23,See treatment for Stage IV disease,c20.A.18
  183. SRC.c20.A.11,see Laser Therapy,p09.a.1
  184. SRC.c20.A.20,see Coping with Treatment Side Effects,p17.a.1
  185. SRC.c20.C.11,see Laser Therapy,p09.c.1
  186. SRC.c20.C.20,see Coping with Treatment Side Effects,p17.c.1
  187. SRC.c23.A.14,see Biological Therapy,p08.a.1
  188. SRC.c23.C.14,see Biological Therapy,p08.c.1
  189. SRC.c24.A.23,See also "Lymphoma: AIDS-Associated",c22.a.1
  190. SRC.c24.A.19,Treatment Overview by Grade,c24.a.12
  191. SRC.c24.C.22,See also "Lymphoma: AIDS-Associated",c22.c.1
  192. SRC.c25.A.15,See also Hyperthermic Perfusion Therapy,p11.a.1
  193. SRC.c25.A.18,see Biological Therapy,p08.a.1
  194. SRC.c25.A.20,see "TREATMENT OVERVIEW",c25.A.15
  195. SRC.c25.C.15,See also Bone Marrow Transplantation,p12.c.1
  196. SRC.c25.C.18,see Biological Therapy,p08.c.1
  197. SRC.c25.C.21,see "TREATMENT OVERVIEW",c25.c.15
  198. SRC.c27.A.1,see "CANCER OF AN UNKNOWN PRIMARY SITE",c07.a.1
  199. SRC.c27.A.8,see "BRAIN TUMORS: ADULT",c05.a.1
  200. SRC.c27.C.1,see "CANCER OF AN UNKNOWN PRIMARY SITE",c07.c.1
  201. SRC.c27.C.8,see "BRAIN TUMORS: ADULT",c05.c.1
  202. SRC.c28.A.7,see "SUPPORTIVE CARE",c28.A.16
  203. SRC.c28.C.14,See Bone Marrow Transplantation,p12.c.1
  204. SRC.c28.C.7,see "SUPPORTIVE CARE",c28.c.17
  205. SRC.c29.A.10,see Diagram in Cervical Cancer,c09.a.4
  206. SRC.c29.A.12,see "TREATMENT FOLLOW-UP",c29.A.22
  207. SRC.c29.A.2,see Diagram in Cervical Cancer,c09.a.4
  208. SRC.c29.A.2,see "OVARIAN GERM CELL TUMORS",c30.a.1
  209. SRC.c29.C.11,see Diagram in Cervical Cancer,c09.c.4
  210. SRC.c29.C.2,see "OVARIAN GERM CELL TUMORS",c30.c.1
  211. SRC.c29.C.3,see Diagram in Cervical Cancer,c09.c.4
  212. SRC.c30.A.1,see Diagram in Cervical Cancer,c09.a.4
  213. SRC.c30.C.2,see Diagram in Cervical Cancer,c09.c.4
  214. SRC.c31.A.1,see "ISLET CELL AND OTHER PANCREATIC CARCINOMAS",c15.a.1
  215. SRC.p05.A.11,SEE "INTRAOPERATIVE RADIATION",p06.A.8
  216. SRC.p05.A.14,see Blood Transfusions & Cancer Treatment,p14.a.1
  217. SRC.p05.C.12,see Blood Transfusions & Cancer Treatment,p14.c.1
  218. SRC.p06.A.13,see Hyperthemic Perfusion Therapy,p11.a.1
  219. SRC.p06.A.17,see "Special Problems of Radiation Patients",p17.a.1
  220. SRC.p06.C.14,see Hyperthermic Perfusion Therapy,p11.c.1.
  221. SRC.p06.C.19,see "Special Nutritional Problems of Radiation Patients",p18.C.14
  222. SRC.p07.A.20,see Bone Marrow Transplantation,p12.a.1
  223. SRC.p07.A.23,see also What Happens in Biological Therapy,p08.a.1
  224. SRC.p07.A.24,see Coping with Treatment,p17.a.1
  225. SRC.p07.A.27,see Guarding Against Infection,p20.a.1
  226. SRC.p07.A.27,see Coping with Treatment,p17.a.1
  227. SRC.p07.A.27,Advances in Cancer Genetics,p36.a.1
  228. SRC.p07.A.9,see What Happens in Surgery,p05.a.9
  229. SRC.p07.C.20,See also Bone Marrow Transplantation,p12.c.1
  230. SRC.p07.C.23,See also What Happens in Biological Therapy,p08.c.1
  231. SRC.p07.C.24,see Coping with Treatment,p17.c.1
  232. SRC.p07.c.27,see Guarding Against Infection,p20.a.1
  233. SRC.p07.c.27,see Coping with Treatment,p17.a.1
  234. SRC.p07.c.27,see Investigational Anticancer Drugs,p35.a.1
  235. SRC.p07.C.9,see What Happens in Surgery,p05.c.9
  236. SRC.p11.A.3,See "MELANOMA",c25.a.1
  237. SRC.p11.C.3,See "MELANOMA",c25.c.1
  238. SRC.p13.C.13,see Coping with Treatment,p17.c.1
  239. SRC.p13.C.14,see How Cancer is Diagnosed,p02.c.1
  240. SRC.P15.C.11,see Palliative Care,p27.c.1
  241. SRC.p16.A.17,see Coping with Treatment,p17.a.1
  242. SRC.p16.A.19,See Deciding to Live,p28.a.1
  243. SRC.p16.C.19,See Deciding to Live,p28.c.1
  244. SRC.p16.A.19,See Survivorship,p31.a.1
  245. SRC.p16.C.17,see Wellness,p30.c.1
  246. SRC.p16.C.19,See Survivorship,p31.c.1
  247. SRC.p17.A.12,see Relaxation,p25.a.1
  248. SRC.p17.C.12,see Relaxation,p25.c.1
  249. SRC.p18.A.3,See Coping with Treatment,p17.a.1
  250. SRC.p18.C.3,See Coping with Treatment,p17.c.1
  251. SRC.p23.C.11,see the section "Hormonal Replacement Therapy in Women",p23.c.19
  252. SRC.p27.A.5,see Controlling Pain,p19.a.1
  253. SRC.p27.C.5,See Controlling Pain,p19.c.1
  254. SRC.p30.A.6,See Relaxation,p25.a.1
  255. SRC.p30.C.5,see Relaxation,p25.c.1
  256. SRC.p35.A.2,see also Deciding on the Appropriate Treatment,p04.a.1
  257. SRC.p35.A.13,see "MISCELLANEOUS DRUGS",p35.a.17
  258. SRC.p35.A.8,see "GROUP C DRUGS",p35.a.12
  259. SRC.p35.C.12,see "Miscellaneous Drugs",p35.c.15
  260. SRC.p35.C.2,see also Deciding on the Appropriate Treatment,p04.c.1
  261. SRC.p35.C.8,see "Group C Drugs",p35.c.12
  262. SRC.p36.A.4,see Understanding Cancer,p01.a.1
  263. SRC.p36.C.4,See Understanding Cancer,p01.c.1
  264. SRC.c06.A.15,shown on PAGE 29 to 42,c06.A.29
  265. SRC.c06.C.15,shown on PAGE 30 to 42,c06.C.30
  266. SRC.P06.A.19,see "HAIR LOSS",P17.A.38
  267. SRC.P06.C.20,see "HAIR LOSS",P17.C.37
  268. SRC.P26.C.8,Coping With Treatment Side Effects,P17.C.1
  269. SRC.P26.A.8,Coping With Treatment Side Effects,P17.A.1
  270. SRC.P26.C.12,Controlling Pain,P19.C.1
  271. SRC.P26.A.12,Controlling Pain,P19.A.1
  272. SRC.C44.A.14,See Stage Ib,C44.A.13
  273. SRC.C44.C.14,See Stage Ib,C44.C.13
  274. SRC.C44.C.15,See Stage Ib,C44.C.13
  275. SRC.C44.A.15,See Stage Ib,C44.A.13
  276. SRC.C44.A.18,See STAGE IIB,C44.A.15
  277. SRC.C44.C.18,See STAGE IIB,C44.C.15
  278. SRC.C44.A.19,See STAGE IB,C44.A.13
  279. SRC.C44.C.19,See STAGE IB,C44.C.13
  280. SRC.P24.A.19,Treatment Overview by Grade,C24.A.12
  281. SRC.P24.C.19,Treatment Overview by Grade,C24.C.12